Literature DB >> 32314899

[Mandibular Langerhans cell histiocytosis: a case report].

Jia-Shun Wu1, Wei-Long Zhang1, Zhu-Feng Li1, Hao-Fan Wang1, Xiao Yang1, Mei Zhang1, Ming-Zhong Yang1, Yu Chen1, Ya-Ling Tang1.   

Abstract

Langerhans cell histiocytosis is commonly found in cranial bones and rarely found in the mandible. This article presents a case of mandibular Langerhans cell histiocytosis and discusses its pathogeny, clinical features, diagnosis, and treatment.

Keywords:  Langerhans cell histiocytosis; clinicopathology; mandibule

Mesh：

Year:  2020        PMID： 32314899      PMCID： PMC7184281          DOI： 10.7518/hxkq.2020.02.019

Source DB:  PubMed          Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi        ISSN： 1000-1182


  14 in total

1.  Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules.

Authors:  J Valladeau; O Ravel; C Dezutter-Dambuyant; K Moore; M Kleijmeer; Y Liu; V Duvert-Frances; C Vincent; D Schmitt; J Davoust; C Caux; S Lebecque; S Saeland
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

2.  Histiocytosis syndromes in children. Writing Group of the Histiocyte Society.

Authors: 
Journal:  Lancet       Date:  1987-01-24       Impact factor: 79.321

3.  Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.

Authors:  Carl E Allen; Liunan Li; Tricia L Peters; Hon-Chiu Eastwood Leung; Alexander Yu; Tsz-Kwong Man; Sivashankarappa Gurusiddappa; Michelle T Phillips; M John Hicks; Amos Gaikwad; Miriam Merad; Kenneth L McClain
Journal:  J Immunol       Date:  2010-03-10       Impact factor: 5.422

4.  Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders.

Authors:  Kudakwashe Chikwava; Ronald Jaffe
Journal:  Pediatr Dev Pathol       Date:  2004-11-08

Review 5.  Langerhans cell histiocytosis in children: History, classification, pathobiology, clinical manifestations, and prognosis.

Authors:  Jolie Krooks; Milen Minkov; Angela G Weatherall
Journal:  J Am Acad Dermatol       Date:  2018-06       Impact factor: 11.527

6.  Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation.

Authors:  Julien Haroche; Fleur Cohen-Aubart; Jean-François Emile; Laurent Arnaud; Philippe Maksud; Frédéric Charlotte; Philippe Cluzel; Aurélie Drier; Baptiste Hervier; Neïla Benameur; Sophie Besnard; Jean Donadieu; Zahir Amoura
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

Review 7.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

Review 8.  Disseminated intravascular coagulation in lupus erythematosus with acute liver damage.

Authors:  Y Shimamoto; M Sano; S Kaneda; S Tsunada; K Yamamoto; M Yamaguchi
Journal:  Intern Med       Date:  1992-12       Impact factor: 1.271

9.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

10.  Potential clinical implications of BRAF mutations in histiocytic proliferations.

Authors:  Anna-Maria Bubolz; Stephanie E Weissinger; Albrecht Stenzinger; Annette Arndt; Konrad Steinestel; Silke Brüderlein; Holger Cario; Anneli Lubatschofski; Claudia Welke; Ioannis Anagnostopoulos; Thomas F E Barth; Ambros J Beer; Peter Möller; Martin Gottstein; Andreas Viardot; Jochen K Lennerz
Journal:  Oncotarget       Date:  2014-06-30
View more
  1 in total

1.  Progressive destruction of jaws caused by the delayed treatment of Langerhans cell histiocytosis in a 2-year-old boy: A case report.

Authors:  Mingmei Meng; Qiong Zhang; Xuedong Zhou; Jing Zou
Journal:  Oral Radiol       Date:  2022-05-10       Impact factor: 1.882
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.